Evidence map›Paper›PMID 38347920›Full record

ArticleFrontiers in physiology2023

Chronic hypoxia disrupts T regulatory cell phenotype contributing to the emergence of exTreg-T

Benjamin J Lantz, Mika Moriwaki, Olufunmilola M Oyebamiji, Yan Guo, Laura Gonzalez Bosc

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Regulatory T cells in hypoxic environments.Frontiers in immunology · 2026
    Review
  4. Article
  5. Recent advances on immunity and hypertension: the new cells on the kidney block.American journal of physiology. Renal physiology · 2025
    Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Benjamin J LantzGonzalez Bosc Laboratory, Health Sciences Center, Cell Biology and Physiology, University of New Mexico, Albuquerque, NM, United States.
Mika MoriwakiGonzalez Bosc Laboratory, Health Sciences Center, Cell Biology and Physiology, University of New Mexico, Albuquerque, NM, United States.
Olufunmilola M OyebamijiDivision of Molecular Medicine, Health Sciences Center, Internal Medicine, University of New Mexico, Albuquerque, NM, United States.
Yan GuoDepartment of Public Health and Sciences, University of Miami, Miami, FL, United States.
Laura Gonzalez BoscGonzalez Bosc Laboratory, Health Sciences Center, Cell Biology and Physiology, University of New Mexico, Albuquerque, NM, United States.
University of New Mexico · USUniversity of Miami · US

Funding

MINORITY INSTITUTIONAL RESEARCH TRAINING PROGRAM (T32)T32HL007736 · NHLBI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI RESTA, THOMAS C · 1993 to 2025
$6.5M
Novel collagen V-reactive natural Th17 cells in hypoxic pulmonary hypertensionR56HL153065 · NHLBI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI GONZALEZ BOSC, LAURA V · 2020 to 2020
$379k
NHLBI NIH HHS R56 HL153065NHLBI NIH HHS T32 HL007736
6 · The paper itself

Abstract

The imbalance between pro-inflammatory T helper 17 (T

Indexed as

CH-induced PHchronic hypoxiaexTregexTreg-TH17immune imbalancepulmonary inflammationTH17Treg

Identifiers

PMID38347920
PMCPMC10859758
OpenAlexW4391321826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.